Susquehanna International Group
LBPSW

Susquehanna International Group’s 4D Pharma PLC Warrant LBPSW Stock Holding History

Susquehanna International Group’s Portfolio LBPSW Stock Details LBPSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,959
Closed -$8K – 14330
2021
Q3 		$8K Buy
+11,959
New +$11.2K ﹤0.01% 12616

Other funds holding LBPSW

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's LBPSW Position: Q4 2021 in Review

Susquehanna International Group sold out of 4D Pharma PLC Warrant (LBPSW) in Q4 2021, closing a stake of 11,959 shares — an estimated $8K sold.

Susquehanna International Group first reported a position in LBPSW in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 5 funds tracked by Wall St. Rank hold LBPSW as of Q4 2021.

  • Susquehanna International Group reported no remaining 4D Pharma PLC Warrant position as of Q4 2021 after selling out during the quarter.
  • Susquehanna International Group sold 11,959 4D Pharma PLC Warrant shares in Q4 2021, an estimated $8K.
  • Susquehanna International Group first reported a position in 4D Pharma PLC Warrant in Q3 2021 and held it in 1 quarter.
  • Susquehanna International Group's 4D Pharma PLC Warrant position peaked at $8K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held 4D Pharma PLC Warrant as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.